🔥36氪•Stalecollected in 25m
AromeManpo secures nearly 100M RMB in Series B funding
💡See how a consumer brand uses physiological data and scientific validation to differentiate in the skincare market.
⚡ 30-Second TL;DR
What Changed
Raised nearly 100M RMB in Series B funding from Yingtong Holdings.
Why It Matters
The brand's integration of physiological data (EEG/cortisol) into skincare product development represents a growing trend of 'quantified wellness' that AI practitioners can leverage for personalized health applications.
What To Do Next
Explore integrating physiological sensor data with LLMs to build personalized wellness recommendation engines.
Who should care:Founders & Product Leaders
Key Points
- •Raised nearly 100M RMB in Series B funding from Yingtong Holdings.
- •Plans to expand offline presence to over 20 stores by 2027.
- •Utilizing EEG and cortisol monitoring to scientifically validate emotional skincare effects.
- •Developing proprietary plant-based ingredients with Jiangnan University.
📰
Weekly AI Recap
Read this week's curated digest of top AI events →
👉Related Updates
AI-curated news aggregator. All content rights belong to original publishers.
Original source: 36氪 ↗